|
Local Faculty
- Prof. Garry
I.
Abelev, Institute of Carcinogenesis, Russian Oncological Research
Center, Moscow.
- Prof. Alexander
S. Apt, Central Institute of Tuberculosis, Moscow
- Prof. Peter M.
Chumakov, Engelhardt Institute of Molecular Biology, Russian
Academy of Sciences, Moscow,
and Lerner Research Institute, Cleveland Clinic Foundation, USA.
- Prof. Alexander
G. Gabibov, Shemyakin-Ovchinnikov Institute of Bioorganic
Chemistry, Russian Academy of Sciences, Moscow
- Prof. Boris P.
Kopnin , Institute of Carcinogenesis, Russian Oncological
Research Center, Moscow.
- Dr. Dmitry
V. Kuprash, Engelhardt Institute of Molecular Biology,
Russian Academy of Sciences, Moscow.
- Prof. Sergei A.
Nedospasov, Engelhardt Institute of Molecular Biology,
Russian Academy of Sciences; Biological Faculty, Moscow State University; Belozersky Institute of Physico-Chemical
Biology, Moscow State University, Moscow.
- Prof. Evgeny I. Rogaev, Mental Health Research Center of RAMS; N.I. Vavilov Institute of General Genetics, RAS; University of Massachusetts
- Prof. Juri M.
Vassiliev, Institute of Carcinogenesis, Russian Oncological
Research Center, Moscow
- Prof.
Alexander
A. Yarilin, Insitute of Immunology,
Moscow; Biological Faculty of Moscow State University, Moscow
Visiting Faculty
- Prof. James P. Allison
, Memorial Sloan-Kettering Cancer Center, New York, USA
- Prof. Adriano
Aguzzi, Institute of Neuropathology,
University of Zurich, Switzerland.
- Prof. Frederick
Alt, Children’s Hospital, Harvard Medical
School; CBR Institute for Biomedical Research, and Howard
Hughes Medical Institute, Boston, USA.
- Prof. Michael
J. Bevan, Department of Immunology, University of Washington
School of Medicine, and Howard Hughes Medical Institute, Seattle, USA
- Prof. Thomas
Blankenstein, Institute of Immunology, Charite Campus Benjamin
Franklin, and Max-Delbruck-Center for Molecular Medicine, Berlin,
Germany
- Prof. Günter
Blobel, Laboratory
of Cell Biology, The Rockefeller University, and Howard Hughes Medical Institute, New York, USA.
- Prof. Thierry
Boon, Ludwig Institute for Cancer Research, Brussels Branch,
Belgium.
- Prof. Michail
Bukrinsky, George Washington University, Washington DC, USA.
- Prof. Tom
Cech, Howard Hughes Medical Institute, Chevy Chase, MD, USA.
- Prof. Alexander
Chervonsky, The University of Chicago, USA.
- Prof. Aaron Ciechanover,
Cancer and Vascular Biology Center, The Rappaport Faculty of Medicine
and Research Institute, Technion-Israel Institute of Technology, Haifa,
Israel.
- Prof. Max Cooper,
Emory University, USA.
- Prof. Charles A Dinarello,
University of Colorado at Denver and Health Sciences Center, USA.
- Prof. Peter
Doherty, St. Jude Children's Research Hospital, Memphis, USA,
and Department of Microbiology and Immunology, The University of
Melbourne, Australia.
- Prof. Don Ganem,
University of California, and Howard Hughes Medical
Institute, San Francisco, CA USA
- Prof. Philip
Greenberg, Department of Medicine and Immunology, University of
Washington School of Medicine, Seattle, USA.
- Dr. Robert J.
Gorelick, Center for Cancer Research, NCI-Frederick,
USA.
- Prof. Andrei
Gudkov, Roswell Park Cancer Institute, Buffalo, NY, USA.
- Dr. Simon Fillatreau, German Rheumatism Research Center, Berlin, Germany.
- Prof. Pamela
J. Fink, Department of Immunology, University of Washington School
of Medicine, Seattle, USA.
- Prof. Richard Flavell,
Yale University School of Medicine, and Howard Hughes
Medical Institute, New Haven, USA
- Prof. Tom A. Hamilton, Lerner Research Institute, Cleveland Clinic Foundation, USA.
- Prof. Adrian
Hayday, GKT School of Medicine, King's College London, England,
United Kingdom.
- Prof. Hans
Hengartner, Institute of Experimental Immunology, University
of Zurich, Switzerland.
- Prof. Jules
Hoffmann, Institute of Molecular and Cellular Biology, CNRS,
Strasbourg, France.
- Dr. Arthur A.
Hurwitz, Center for Cancer Research, NCI-Frederick, USA
- Prof. Elke
Jager, Krankenhaus Nordwest, Frankfurt am Main, Germany.
- Prof. Victor
Jongeneel , Ludwig Institute for Cancer Research, and Swiss
Institute for Bioinformatics, Lausanne, Switzerland.
- Prof. Michael
Karin, University of California, San Diego, La Jolla, CA, USA.
- Dr. Jonathan
Keller, Center for Cancer Research,
NCI-Frederick, USA.
- Prof. Eva Klein,
Karolinska Institutet, Stockholm, Sweden.
- Prof. George
Klein, Karolinska Institutet, Stockholm, Sweden.
- Prof. Alex
Knuth, Department of Oncology, University of Zurich,
Switzerland.
- Dr. Sergei V.
Kozlov, Center for Cancer Research,
NCI-Frederick, MD, USA.
- Prof. Peter
Krammer, Department of Immunogenetics, German Cancer Research
Center, Heidelberg, Germany.
- Prof. Yuri Lazebnik,
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
- Prof. Arnold
Levine, Simons Center for Systems Biology, Institute for Advanced Studies, , Princeton, USA.
- Prof. Victor
Levitsky, Johns
Hopkins University, Baltimore, MD, USA
- Prof.
Dan
Littman,
New York University, and Howard Hughes Medical Institute, USA
- Prof. Jean-Pierre
Mach, Faculty of Medicine and Institute of Biochemistry,
University of Lausanne, Switzerland.
- Prof. Diane
Mathis, Harvard Medical School, Boston, USA.
- Prof. Ruslan
Medzhitov, Yale University School of Medicine, and
Howard Hughes Medical Institute, New Haven, USA
- Prof. William
J. Murphy, UC Davis Department of Dermatology, USA.
- Prof. Alfred
Nordheim, University of Tubingen, Germany.
- Prof. Michael
Pfreundschuh, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Germany.
- Prof. Alexander
Poltorak, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, USA.
- Prof. Klaus
Rajewsky, Harvard Medical School, Boston, USA.
- Prof. Hans-Georg
Rammensee, Department of Immunology, University of Tubingen, Germany
- Prof. David Raulet
, Division of Immunology, University of California, Berkeley, USA
- Prof. Michael
Reth, Department of Molecular Immunology, University of Freiburg,
Germany
- Prof. Alexander
Rudensky, Memorial Sloan-Kettering Cancer Center, and Howard Hughes
Medical Institute, New York, USA.
- Prof. Joseph
Schlessinger, Department of Pharmacology, Yale School of Medicine,
New Haven, USA.
- Prof. Wolf-Dieter
Schleuning, University of Bielefeld, Germany.
- Prof. Hans
Schreiber, The University of Chicago, USA.
- Prof. Robert
Schreiber, Washington University School of Medicine, St. Louis,
MO, USA.
- Prof. Svetlana P.
Sidorenko, R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology, National Academy of Sciences of Ukraine,
Kyiv, Ukraine.
- Prof. Andrew
Simpson, Ludwig Institute for Cancer Research, New York, USA.
- Prof. Pramod
Srivastava, University of Connecticut Health Center,
Farmington, CT, USA
- Prof. Jan Svoboda,
Institute of Molecular Genetics, Academy of Sciences of Czech Republic,
Prague, Czech Republic
- Prof. Alexei
Terskikh, The Burnham Institute,
La Jolla, USA
- Dr. Lino
Tessarollo, Center for Cancer Research, NCI-Frederick, MD, USA.
- Prof. Craig Thompson,
Abramson Cancer Center of the University of Pennsylvania,
Philadelphia, USA.
- Prof. Giorgio
Trinchieri, Center for Cancer Research,
NCI-Frederick,
USA.
- Prof. Tadatsugu
Taniguchi, University of Tokyio, Japan.
- Prof. Harold Varmus,
Memorial Sloan-Kettering Cancer Center, New York, USA
- Prof. Tchavdar Vassilev,
The Stephan Angeloff Institute of Microbiology, Sofia, Bulgaria
- Prof. Jan T.
Vilcek, New York University School of Medicine, USA.
- Prof. James
D. Watson, Cold Spring Harbor Laboratory, NY, USA.
- Prof. Robert
Weinberg , Whitehead Institute and Massachusetts Institute of
Technology, Cambridge, USA.
- Prof. Boris Zhivotovsky,
Institute of Environmental Medicine, Karolinska Institute, Stockholm,
Sweden.
- Prof. Rolf
Zinkernagel, Institute of Experimental Immunology, University of
Zurich, Switzerland.
- Prof. Harald
zur Hausen, German Cancer Research Center, Heidelberg, Germany
Home
|
|